Cancer breakthrough could be new way of identifying deadly disease
A new cancer breakthrough could prove to be a gamechanger for preventing the spread of breast cancer to other vital organs ...
Hosted on MSN20h
BMJ’s Phase III Opdualag study fails to meet endpoints
The combination therapy failed to beat out the company’s other cancer therapy, Opdivo, in patients living with melanomas.